Kang KW - Search Results

1

Radiation-induced exosomal miR-21 enhances tumor proliferation and invasiveness in breast cancer: implications for poor prognosis in radiotherapy patients.

Kim K, Jung KO, Oh S, Kim YH, Lee SY, Hong S, Cho SH, Kim H, Rhee S, Cheon GJ, Kang KW, Chung JK, Youn H. Kim K, et al. Among authors: kang kw. Exp Hematol Oncol. 2024 Dec 18;13(1):120. doi: 10.1186/s40164-024-00585-5. Exp Hematol Oncol. 2024. PMID: 39695874 Free PMC article.

2

Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells.

Jung KO, Youn H, Lee CH, Kang KW, Chung JK. Jung KO, et al. Among authors: kang kw. Oncotarget. 2017 Feb 7;8(6):9899-9910. doi: 10.18632/oncotarget.14247. Oncotarget. 2017. PMID: 28038441 Free PMC article.

3

Efficacy and Safety of Human Serum Albumin-Cisplatin Complex in U87MG Xenograft Mouse Models.

Park CR, Kim HY, Song MG, Lee YS, Youn H, Chung JK, Cheon GJ, Kang KW. Park CR, et al. Among authors: kang kw. Int J Mol Sci. 2020 Oct 26;21(21):7932. doi: 10.3390/ijms21217932. Int J Mol Sci. 2020. PMID: 33114661 Free PMC article.

4

Imaging in Tumor Immunology.

Kim EE, Youn H, Kang KW. Kim EE, et al. Among authors: kang kw. Nucl Med Mol Imaging. 2021 Oct;55(5):225-236. doi: 10.1007/s13139-021-00706-6. Epub 2021 Jul 27. Nucl Med Mol Imaging. 2021. PMID: 34721715 Free PMC article. Review.

5

Glucose-Thymidine Ratio as a Metabolism Index Using ¹⁸F-FDG and ¹⁸F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy.

Oh S, Youn H, Paeng JC, Kim YH, Lee CH, Choi H, Kang KW, Chung JK, Cheon GJ. Oh S, et al. Among authors: kang kw. Int J Mol Sci. 2022 Aug 17;23(16):9273. doi: 10.3390/ijms23169273. Int J Mol Sci. 2022. PMID: 36012530 Free PMC article.

6

Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.

Im HJ, Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ, Chung JK, Kim EE, Lee DS. Im HJ, et al. Among authors: kang kw. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):241-51. doi: 10.1007/s00259-014-2903-7. Epub 2014 Sep 6. Eur J Nucl Med Mol Imaging. 2015. PMID: 25193652

7

Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.

Kim YH, Youn H, Na J, Hong KJ, Kang KW, Lee DS, Chung JK. Kim YH, et al. Among authors: kang kw. Theranostics. 2015 Jan 1;5(1):86-96. doi: 10.7150/thno.10062. eCollection 2015. Theranostics. 2015. PMID: 25553100 Free PMC article.

8

Prognostic Implications of the SUVmax of Primary Tumors and Metastatic Lymph Node Measured by 18F-FDG PET in Patients With Uterine Cervical Cancer: A Meta-analysis.

Sarker A, Im HJ, Cheon GJ, Chung HH, Kang KW, Chung JK, Kim EE, Lee DS. Sarker A, et al. Among authors: kang kw. Clin Nucl Med. 2016 Jan;41(1):34-40. doi: 10.1097/RLU.0000000000001049. Clin Nucl Med. 2016. PMID: 26505856

9

Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.

Yoo MY, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, Kang KW. Yoo MY, et al. Among authors: kang kw. Nucl Med Mol Imaging. 2015 Dec;49(4):291-7. doi: 10.1007/s13139-015-0362-0. Epub 2015 Aug 29. Nucl Med Mol Imaging. 2015. PMID: 26550048 Free PMC article.

10

A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM.

Jung KO, Youn H, Kim SH, Kim YH, Kang KW, Chung JK. Jung KO, et al. Among authors: kang kw. Biochem Biophys Res Commun. 2016 Aug 26;477(3):483-9. doi: 10.1016/j.bbrc.2016.06.068. Epub 2016 Jun 15. Biochem Biophys Res Commun. 2016. PMID: 27317485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

867 results

Search Page

Filters